BX Swiss TOP 30 CHF
1.384,48
PKT
+20,50
PKT
+1,50
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.03.22 | UBS Outperform | RBC Capital Markets | |
| 30.03.22 | UBS Buy | Jefferies & Company Inc. | |
| 30.03.22 | UBS Hold | Jefferies & Company Inc. | |
| 30.03.22 | Nestlé Neutral | Credit Suisse Group | |
| 29.03.22 | Givaudan Neutral | UBS AG | |
| 29.03.22 | Givaudan Hold | Deutsche Bank AG | |
| 29.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 29.03.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 28.03.22 | Givaudan Neutral | UBS AG | |
| 28.03.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 28.03.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 25.03.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.03.22 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.03.22 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.03.22 | Swiss Re Hold | Jefferies & Company Inc. | |
| 23.03.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 23.03.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 22.03.22 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.03.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.03.22 | Zurich Insurance Outperform | Credit Suisse Group | |
| 22.03.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.03.22 | Richemont Overweight | Barclays Capital | |
| 17.03.22 | Nestlé Sector Perform | RBC Capital Markets | |
| 17.03.22 | Holcim Outperform | Credit Suisse Group | |
| 16.03.22 | Swiss Re Sell | UBS AG | |
| 16.03.22 | Swiss Re Hold | Deutsche Bank AG | |
| 16.03.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 15.03.22 | Richemont Outperform | RBC Capital Markets | |
| 14.03.22 | Givaudan Neutral | UBS AG | |
| 14.03.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.03.22 | Nestlé Outperform | Bernstein Research | |
| 14.03.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 14.03.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 11.03.22 | Givaudan Neutral | UBS AG | |
| 11.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 10.03.22 | UBS Neutral | UBS AG | |
| 10.03.22 | UBS Sector Perform | RBC Capital Markets | |
| 09.03.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 09.03.22 | Givaudan Hold | Deutsche Bank AG | |
| 08.03.22 | UBS Sector Perform | RBC Capital Markets |